Navigation Links
NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009

ANN ARBOR, Mich., March 2 /PRNewswire/ -- NanoBio Corp. announced today that it will present compelling new data highlighting key clinical and preclinical milestones in the development of its novel topical treatments for herpes labialis, onychomycosis and tinea capitis. The new data will be delivered in five presentations during the 2009 meeting of the American Academy of Dermatology in San Francisco, March 6-9, 2009.

In addition to the oral poster presentations listed below, the presentations will be available electronically at the kiosks provided by the AAD during the conference. NanoBio will also sponsor corporate booth # 5284, where information on the company's development programs for acne, herpes and antifungal products will be available.

Oral Poster Presentations

Saturday, March 7, 2009 -- Center 3

Poster # P2411, 10:20 a.m. -- Antifungal Activity and Mechanism of Action of NB-002, a Novel Topical Antifungal, Against the Major Pathogens of Onychomycosis

Poster # P2423, 12:20 p.m. -- Antifungal Activity of NB-002, a Topical Nanoemulsion, Against Rare Fungal Pathogens of Onychomycosis

Poster # P2505, 2:00 p.m. -- Investigator Assessed Time to Healing in a Randomized, Double-Blind, Vehicle-Controlled Trial of a Novel Antiviral Nanoemulsion (NB-001) for Recurrent Herpes Labialis

Poster # P2517, 4:00 p.m. -- Safety, Tolerability and Pharmacokinetics of Topical NB-001 (0.1%, 0.3% and 0.5%) for the Treatment of Recurrent Herpes Labialis

Sunday, March 8, 2009 - Center 1

Poster # P2114, 10:40 a.m. -- A Randomized, Double-Blind, Vehicle-Controlled Trial of Novel Topical Antifungal Nanoemulsion (NB-002) in Subjects With Distal Subungual Onychomycosis

About NanoBio

NanoBio(R) Corp. is a privately held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccines derived from its patented NanoStat(TM) technology platform. The company's lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), acne, cystic fibrosis and a broad platform of intranasal vaccines. The company's headquarters and laboratory facilities are located in Ann Arbor, Michigan.

SOURCE NanoBio Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria
2. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
3. NanoBio Wins 2007 Michigan Innovation Award
4. MedThink Communications Retained by NanoBio Corporation
5. MHA Announces: Launch of New Website
6. National Instruments Announces New Suite of Prototyping Hardware to Lower Development Time and Costs
7. Lilly Announces Leadership Changes
8. Availity Announces Support of Project SwipeIT
9. The Vitality Group Announces Expansion to Board of Directors
10. Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
11. Boston Scientific Announces Election Of John Sununu To Its Board Of Directors
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
(Date:6/23/2016)... Ill. and INDIANAPOLIS , ... students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is ... 2016 scholarship winners, announced today online at ... let type 1 diabetes stand in the way of ... has supported the Foundation,s scholarship program since 2012, and ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology: